Lite satsing på kreftinnovasjon
Statsbudsjettet for 2022 inneholder lite for kreftpasienter og innovasjon innen kreftbehandling.
Our role as Changemaker
Did you know that Oslo Cancer Cluster is a changemaker?
NOK 16 million to new RWE company
The Research Council of Norway recently awarded grants to several innovation projects in the industrial sector. One of the lucky companies was the newcomer NordicRWE.
The Future of Cancer Treatment
For six years we have hosted The Future of Cancer Treatment (Fremtidens kreftbehandling) with the same partners. What is this seminar series all about?
Bjørn Atle Bjørnbeth joins the board
Dr. Bjørn Atle Bjørnbeth joined the board of Oslo Cancer Cluster during the annual general meeting.
Nye kreftbehandlinger krever nye samarbeidsformer
Debattinnlegg: Innføring av nye legemidler for små pasientgrupper tar unødvendig lang tid. Noen blir ikke tatt i bruk i Norge i det hele tatt. Det er en utfordring, skriver artikkelforfatterne.
